甘李药业:GZC8072片获准开展体重控制临床试验

智通财经
Aug 24
【甘李药业:GZC8072片获准开展体重控制临床试验】甘李药业公告,公司全资子公司甘李药业山东有限公司于近日收到国家药品监督管理局下发的GZC8072片《药物临床试验批准通知书》,同意开展体重控制适应症临床试验。该产品为治疗用生物制品1类。截至2026年3月31日,项目累计投入研发费用4695.53万元人民币。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10